CRL vs ELTX · rev $2.00B vs $132.3M cap
Charles River Laboratories (CRL) versus Elicio Therapeutics Inc. (ELTX) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Elicio Therapeutics Inc. (ELTX) is a biotechnology company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
ELTX does not have a complete income-statement cache yet.
CRL currently screens at market cap $7.78B. ELTX currently screens at market cap $132.3M.
Not investment advice. Open the CRL and ELTX stock pages for the full models.
Not investment advice.